← Devices & Neurotechnology
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry-results
Desyncra Tinnitus Therapy System vs CBT study
Also known as: Desyncra, Desyncra for Tinnitus Therapy System, Cognitive Behavioral Therapy, CBT, PVARF-387005, NCT03022084
Desyncra, Inc.
Sponsor / Institution
Desyncra, Inc.
Program Type
Software/Neurotech
Modality
Hearing Aid/Software
Stage
Interventional/NA
Status
Completed
Target Gene
—
Route / Mode
Sound-therapy device
Confidence
86%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-09
Geography
United States
Population
adult, tinnitus, sound-therapy, behavioral-comparator
Trial IDs
1
Mechanism
Customized sound-therapy device compared with standard-of-care cognitive behavioral therapy for bothersome tonal tinnitus.
Indications
Notes
Split from the generic Cognitive Behavioral Therapy record. The lead sponsor is the VA National Center for Rehabilitative Auditory Research, with Desyncra listed as industry collaborator and product intervention. Results are posted on ClinicalTrials.gov.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, aliases, company, allCompanies, programType, stage, status, route...
IDs: NCT03022084, PVARF-387005, Desyncra
Key Events
Clinical Trials (1)
Data Checks
split-from-generic-cbt-recordindustry-collaborator-not-primary-sponsorresults-posted
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Lenire Tinnitus Treatment Device
Company: Neuromod Devices · Neuromodulation · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed
Auricle Tinnitus Device
Company: Auricle Inc. · Neuromodulation · Phase 2
ReSound Vivia
Company: GN ReSound · Hearing Aid/Software · Marketed